title: [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
abstract: Ovarian borderline tumors are rare, their good prognosis depending on their stage at the time of diagnosis, and the presence of invasive implants. There is little information on tumor type identified intra-surgically, as well as on the most favorable treatment in borderline ovarian tumors.
  
  
  OBJECTIVE
  To determine the criteria of identification and presurgery and intra-surgery differentiation of the ovarian borderline tumors from the invasive carcinoma and benign ovarian tumors.
  
  
  METHODS
  This study included 54 patients with TPMS (ovarian borderline tumors) surgically treated in the past 22 years (January 1988-December 2009) at the 4th Gynecological Clinic of the lasi "Gr. T. Popa" University of Medicine and Pharmacy. In this interval 1,107 ovarian tumors: 575 benign, 478 malignant, and 54 TPMS (4.87%) were recorded. The age of the patients with borderline tumors ranged between 20 and 78 years, mean age 46 years, and the histological types were: mucinous (27 cases), serous (18 cases), mixed (8 cases), and Brenner tumor (1 case).
  
  
  RESULTS
  We have analyzed the distribution of these cases according to the time when surgical treatment was performed. The frequency of borderline ovarian tumors in our study is 4.87%, lower than in the literature. We believe that this low percentage in our study is due to missing the microscopic data in some macroscopic benign tumors.
  
  
  CONCLUSIONS
  By this research we aimed at elaborating a therapeutic strategy for each case using with discernment the modern treatment (surgery, chemotherapy, radiotherapy), as well as new chemical drugs with the goal of obtaining better results and longer survival. There are no tumor markers which could predict the progression of a borderline ovarian tumor to invasive tumors, but the invasive course is only 0.7%.
authors.affiliation: Universitătii de Medicină şi Farmacie Gr. T. Popa, Iaşi.
authors.forename: Alina-Mihaela
authors.initials: AM
authors.lastname: Luchian
authors.forename: M
authors.initials: M
authors.lastname: Pricop
mesh_terms: D000328:Adult; D000368:Aged; D001948:Brenner Tumor / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D018291:Cystadenoma, Mucinous / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D018293:Cystadenoma, Serous / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D005260:Female; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D012189:Retrospective Studies; D012383:Romania / Q000453:epidemiology